姓名： 楊堉麟 教授 (Yang Yu-Lin, PhD, Professor)

 專線：（06）2674567*650

 傳真：（06）2693348

 信箱：call0955443221@gmail.com            

現職 (Present job)

中華醫事科技大學 醫事學院院長 (2021.8.至今)
中華醫事科技大學 醫學檢驗暨生物技術系教授  /  生物醫學研究所教授 (2008-至今)
印尼Universitas Muhammadiyah Surabaya 合聘教授（2026.4-）
高雄醫學大學生命科學院合聘教授（預2026.8-）

學經歷 (Education)

高雄醫學大學醫學技術學系畢業,  直升醫學研究所碩士 , 直升醫學研究所博士

高雄醫學大學醫學研究所博士第一名畢業 (併獲年度博士優秀論文獎)

     澳洲昆士蘭大學生物醫學研究所 交換學者 臺澳雙邊計畫（澳洲皇家科學院補助）

經歷 (Experience)

擔任TIPPA及WIIPA（世界發明智慧財產聯盟總會）國際評審（2018-2021）

受邀擔任政府醫事公職人員命題典試委員（2018）

台澳雙邊計畫 (102WMRFDD500008) 澳洲昆士蘭大學生物醫學研究所訪問教授 (2013)

行政院科技部 (原國科會) 科技專題計畫學術審查委員 (2013-2017)

教育部 學術審查委員會外審委員

中華醫事科技大學 副校長 (2015.6-2020)

中華醫事科技大學教務處 教務長 (2013-2020)

擔任南科管理局研發精進計畫審查委員(2011)

中華醫事科技大學學生事務處 學生事務長 (2008-2013)

高雄醫學大學校友總會 理事/ 榮譽理事 (2008-2014)

教育部南區區域教學資源中心委員 (2008-2011)

高雄醫學大學醫學技術學系校友會會長 (2007-2009)

中華醫事科技大學生物醫學研究所 創所暨籌備所長 (2007)

台南市與台南縣 SBIR計畫審查委員 (2007-2000)

中華醫事科技大學生物安全委員會主任委員 (2004-2013)

中華醫事科技大學生物科技系創系系主任 (2002-2007)

榮譽 (Honor)

獲選教育部107年度 師鐸獎(teacher of the year) 2018 

     (註：全國大學僅8位入選) ※106年師鐸獎－楊堉麟教授

參與中華民國世界發明家競賽獲得第二屆國家品質菁英獎

獲教育部科技校院提升務專業管理能力計畫 (連獲2年500萬)

獲教育部教學卓越計畫 (全國新進教學卓越學校第一名)

獲2013年度第13屆馬來西亞國際發明展ITEX發明競賽金牌

獲教育部全國大專院校友善校園績優學校

獲教育部全國學生事務評鑑一等佳績

獲科技部傑出優秀學者養成計畫補助

獲教育部第一屆全國大學特殊優秀人才彈性薪資獎勵

獲教育部全民國防教育評鑑一等績優學校

推動品德教育獲教育部全國品德教育績優學校

獲選教育部全國唯一連獲六年全國大學頂尖研發人才實施特殊優秀人才彈性薪資補助 

 (註：全國獲選率 6%, 生技生醫領域為全國私校唯一獲獎)

獲選國科會獎勵特殊優秀人才措施之計畫核定 (99年度, 102年度)

行政院國科會專案研究計畫連續 12 年獲補助 (2001-2012)

獲選國科會三年期(99-101)傑出學者養成計畫 (99-2628-B-273-001-MY3)

(註：獲補助金額 4,110,000 元 為全國私立科大補助金額最高)

教育部產業園區產學專案計畫計畫主持人連獲 3 年補助  (2008-2010)

行政院國科會腎臟內分泌學門全國計畫排名第一 (2004)

教育部發展學校重點特色專案計畫主持人(2001,2002)  

　

Academic Background

Graduated from the Department of Medical Technology, Kaohsiung Medical University, and directly advanced to complete both M.S. and Ph.D. degrees in the Institute of Medicine. Ranked 1st in his cohort, with early publications in top-tier U.S. endocrine journals.

Awarded a prestigious scholarship from the Royal Academy of Sciences (Australia), and served as an exchange scholar at the University of Queensland, School of Biomedical Sciences, gaining international research training.

Academic Appointments & Leadership

Appointed Full Professor at age 37 by Taiwan’s Ministry of Education. Over 25 years of continuous academic and administrative leadership, holding key positions including: Department Chair, Director, Dean of Student Affairs, Dean of Academic Affairs, Secretary-General, and Vice President.

Research Productivity & Innovation Output

Published almost 60 SCI-indexed international journal papers over the past 20 years. Filed 34 invention patents within the same period. Applied for ~20 core patents across Taiwan, the United States, China, Japan and Malaysia. Delivered invited academic lectures across multiple countries (USA, Germany, China, Australia, Dubai, Singapore, Indonesia, etc.)

Research Funding & Project Leadership

Secured over USD 15 million in competitive research and institutional funding. Led and executed multiple national-level projects, including NSTC (National Science and Technology Council), SBIR, and industry–academia collaboration programs, with cumulative funding exceeding USD 1.6 million in targeted innovation initiatives. Recipient of: Outstanding Young Scholar Award (NSTC), MOE Elite Talent Flexible Salary Subsidy Program (6 consecutive years; total support of approximately USD 100,000)

Academic Excellence & Educational Impact

l   Recipient of the National Teacher of the Year Award (2018), awarded by the President of Taiwan

l   Led character education reform, awarded Excellence in Character Education (MOE, 2008)

l   Promoted campus innovation, awarded National Model Campus Award (MOE, 2011)

l   As Dean of Academic Affairs:

l   Secured NT$80 million (Teaching Excellence Project, 2015–2016)

l   Further expanded funding by NT$120 million (2017–2019)

National & International Awards

l   Presidential Award for Innovation in Biomedical Research (2022)

l   National Quality Elite Award (Top 2 of 530 institutions nationwide)

l   ITEX Malaysia Gold Medal + Special Awards (Hong Kong & South Korea, 2023)

l   Bangkok International Invention Fair Gold Medal + Korea Special Award (2025)

Global Academic Collaboration

l   Established international collaborations with leading institutions, including:

l   National Taiwan University (NTU) – NRF Stem Cell Rejuvenation Program

l   National University of Singapore (NUS) – TELMIND-NRF Cognitive Rejuvenation Project

l   Universitas Pelita Harapan (UPH), Indonesia – NRF Anti-Aging Clinical Research Initiative

l   These collaborations focus on telomere biology, cognitive aging, regenerative medicine, and translational biomedical innovation.

Innovation, Patents & Translational Platform

l   Principal innovator of the NRF Platform, a next-generation regenerative biotechnology system targeting:

l   Telomere repair and stabilization

l   Mitochondrial activation

l   Stem cell proliferation and differentiation

l   This platform bridges academic discovery, clinical translation, and industrial commercialization, forming a globally scalable biomedical innovation model.

Research Focus

l   Telomere biology and cellular aging

l   Mitochondrial bioenergetics and metabolic regulation

l   Stem cell biology and regenerative medicine

l   Translational nutraceuticals and biomedical innovation

Professional Profile

Prof. Yang is a leading translational scientist and academic leader in Asia, specializing in the integration of telomere biology and mitochondrial science for next-generation anti-aging and regenerative medicine.

His work uniquely spans fundamental research, national-level policy influence, and global commercialization strategy, positioning him as a key figure in advancing precision longevity science and biomedical innovation.

　

Publications of Prof. Yu-Lin Yang 

1. Wu HH, Hsieh PF, Shi MD, Ko CH, Wu CH, Lin VC, Liu SF, Hung YJ, Hung TS, Wang IC, Yang YL. Nuclear Respiratory Factor 1 (NRF1): A Multifaceted Regulator in Lung Cancer Progression and Therapeutic Targeting. Cancer Genomics & Proteomics. 2026 (In Press)
2. Mai HC, Hsieh PF, Huang WL, Yang YL, Wu CH, Wu RC, Chen SH, Lin VC, Wang CT. Salvianolic Acid Activates ATP-Driven Mitochondrial Biogenesis to Suppress the Epithelial–Mesenchymal Transition in LNCaP Prostate Cancer Cells. Advances in Pharmacological and Pharmaceutical Sciences. 2026; 2026:6660395 (In Press)
3. Chen SH, Wu RC, Huang WL, Wu CH, Mai HC, Yang YL, Hsieh PF, Lin VC, Ou CH. Rutin Suppresses EMT and Induces Mitochondrial Biogenesis via ER Stress-linked AMPK/SIRT1 Signaling in Prostate Cancer Cells. Cancer Genomics & Proteomics. 2025 Nov-Dec;22(6):971-990.
4. Huang WL, Hsieh PF, Chen SH, Wu RC. SCAMP3 and EPS8 Cooperatively Regulate EGFR Signaling to Promote Prostate Cancer Progression. Cancer Genomics & Proteomics. 2025 Nov-Dec;22(6):953-970.
5. Mai HC, Hsieh PF, Wu CH, Wu RC, Chen SH, Huang WL, Tung MC, Yang YL, Lin VC, Wang CT. Verbascoside Suppresses Epithelial–Mesenchymal Transition and Mitochondrial Biogenesis by Targeting Anti-senescence Signaling in Castration-resistant Prostate Cancer. Cancer Genomics & Proteomics. 2025 Nov-Dec;22(6):1044-1060.
6. Lee YH, Wu RC, Mai HC, Huang WL, Wu CH, Yang YL, Hsieh PF, Lin VC. The Regulatory Role of Nuclear Respiratory Factor 1 in Bladder Cancer Cells. Anticancer Research. 2023 Apr;43(4):1521-1531.
7. Wu CH, Hsieh PF, Lee YH, Kuo WWT, Wu RC, Lin YY, Hung CH, Hsieh ML, Pang ST, Yang YL, Lin VC. Nuclear Respiratory Factor 1 Overexpression Inhibits Proliferation and Migration of PC3 Prostate Cancer Cells. Cancer Genomics & Proteomics. 2022 Sep-Oct;19(5):614-623.
8. Wu CH, Chen CH, Hsieh PF, Lee YH, Kuo WWT, Wu RC, Hung CH, Yang YL, Lin VC. Verbascoside Inhibits the Epithelial–Mesenchymal Transition of Prostate Cancer Cells through High-Mobility Group Box 1/Receptor for Advanced Glycation End-products/TGF-β Pathway. Environmental Toxicology. 2021 Jun;36(6):1080-1089.
9. Chen CA, Chang JM, Yang YL, Chang EE, Chen HC. Macrophage Migration Inhibitory Factor Regulates Integrin-β1 and Cyclin D1 Expression via ERK Pathway in Podocytes. Biomedicine & Pharmacotherapy. 2020 Apr;124:109892.
10. Hwang JY, Kan WC, Liu YB, Chuang LY, Guh JY, Yang YL, Huang JS. Angiotensin-converting Enzyme Inhibitors Attenuated Advanced Glycation End Products-induced Renal Tubular Hypertrophy via Enhancing Nitric Oxide Signaling. Journal of Cellular Physiology. 2019 Mar 1. doi:10.1002/jcp.28369.
11. Kan WC, Hwang JY, Chuang LY, Guh JY, Ye YL, Yang YL, Huang JS. Effect of Osthole on Advanced Glycation End Products-induced Renal Tubular Hypertrophy and Role of Klotho in Its Mechanism of Action. Phytomedicine. 2019 Feb;53:205-212.
12. Chen CA, Chang JM, Chang EE, Chen HC, Yang YL. Crosstalk between Transforming Growth Factor-β1 and Endoplasmic Reticulum Stress Regulates Alpha-smooth Muscle Cell Actin Expression in Podocytes. Life Sciences. 2018;209:9-14.
13. Chen CA, Chang JM, Chang EE, Chen HC, Yang YL. TGF-β1 Modulates Podocyte Migration by Regulating the Expression of Integrin-β1 and -β3 through Different Signaling Pathways. Biomedicine & Pharmacotherapy. 2018;105:974-980.
14. Wang JL, Chen CW, Tsai MR, Liu SF, Hung TJ, Hung YJ, Chang WT, Shi MD, Hsieh PF, Yang YL. Antifibrotic Role of PGC-1α-siRNA against TGF-β1-induced Renal Interstitial Fibrosis. Experimental Cell Research. 2018 Jun 18.
15. Hsieh PF, Yang YL. Renal Fibrosis and Mitochondrial Biogenesis. Diabetes, Metabolic Disorders & Control. 2016 Nov 10.
16. Wang JL, Chen YJ, Hsieh PF, Liu SF, Hung TJ, Hung CY, Shi MD, Hung YJ, Hung TS, Shiue YL, Yang YL. Verbascoside Reverses TGF-β1-Induced Renal Cellular Fibrosis. Diabetes, Metabolic Disorders & Control. 2016 Oct 28.
17. Hsieh PF, Liu SF, Hung TJ, Hung CY, Liu GZ, Chuang LY, Chen MF, Wang JL, Shi MD, Hsu CH, Shiue YL, Yang YL. Elucidation of the Therapeutic Role of Mitochondrial Biogenesis Transducers NRF-1 in the Regulation of Renal Fibrosis. Experimental Cell Research. 2016 Nov 15.
18. Hsieh PF, Liu SF, Hung TJ, Hung CY, Liu GZ, Chuang LY, Chen MF, Wang JL, Shi MD, Hsu CH, Shiue YL, Yang YL. Treatment with Cytokine Thymic Stromal Lymphopoietin Short Hairpin RNA Substantially Reduces TGF-β1-induced Interstitial Cellular Fibrosis. Experimental Cell Research. 2016 Jul.
19. Hung CY, Ma SJ, Liu SF, Hsieh PF, Yang YL. Water Extract of Osmanthus Fragrans Attenuates TGF-β1-induced Lung Cellular Fibrosis in Human Lung Fibroblasts Cells. International Journal of Pharmacological Research. 2015.
20. Wang WC, Liu SF, Chang WT, Shiue YL, Hsieh PF, Hung TJ, Hung CY, Hung YJ, Chen MF, Yang YL. The Effects of Diosgenin in the Regulation of Renal Proximal Tubular Fibrosis. Experimental Cell Research. 2014 May 1;323(2):255-262.
21. Chen MF, Tsai JT, Chen LJ, Wu TP, Yang JJ, Yin LT, Yang YL, Chiang TA, Lu HL, Wu MC. Characterization of Imidazoline Receptors in Blood Vessels for the Development of Antihypertensive Agents. BioMed Research International. 2014;2014:182846.
22. Chen MF, Tsai JT, Chen LJ, Wu TP, Yang JJ, Yin LT, Yang YL, Chiang TA, Lu HL, Wu MC. Antihypertensive Action of Allantoin in Animals. BioMed Research International. 2014;2014:690135.
23. Hung TJ, Liu SF, Liu GZ, Hsieh PF, Chuang LY, Guh JY, Hsieh CC, Hung YJ, Shiue YL, Yang YL. shRNA for Thymic Stromal Lymphopoietin: A Novel Therapeutic Approach for Pulmonary Fibrosis. Journal of Cell Science & Therapy. 2013;4(3).
24. Huang YH, Lin CC, Jhao CL, Yang YL, Lee TC. Polymerase Chain Reaction as the Sole Diagnostic Tool for Sacral-Spinal Tuberculosis. Surgical Infections. 2013 Apr 5.
25. Ko YM, Chang CY, Chiou SJ, Hsu FJ, Huang JS, Yang YL, Guh JY, Chuang LY. Ubiquitin C-terminal Hydrolase-L5 Is Required for High Glucose-induced Transforming Growth Factor-receptor I Expression and Hypertrophy in Mesangial Cells. Archives of Biochemistry and Biophysics. 2013 Mar 12.
26. Liu SF, Chang SY, Lee TC, Chuang LY, Guh JY, Hung CY, Hung TJ, Hung YJ, Chen PY, Hsieh PF, Yang YL. Dioscorea alata Attenuates Renal Interstitial Cellular Fibrosis by Regulating Smad- and Epithelial-Mesenchymal Transition Signaling Pathways. PLoS ONE. 2012.
27. Hung TJ, Chen WM, Liu SF, Liao TN, Lee TC, Chuang LY, Guh JY, Hung CY, Hung YJ, Chen PY, Hsieh PF, Yang YL. 20-Hydroxyecdysone Attenuates TGF-β1-induced Renal Cellular Fibrosis in Proximal Tubule Cells. Journal of Diabetes and Its Complications. 2012 Aug 1.
28. Hung TJ, Liu GZ, Liu SF, Lee TC, Chuang LY, Guh JY, Hsieh CC, Yang YL. shRNA for Thymic Stromal Lymphopoietin as a Novel Antagonist for Pulmonary Fibrosis. Molecular Therapy. 2012;20(Suppl 1):S92.
29. Yang YL, Liu SF, Liu GZ, Lee TC, Chuang LY, Guh JY, Yang YY, Liao TN, Hung TJ, Hung MY. TSLP shRNA Attenuates TGF-β1-induced Renal Interstitial Fibrosis. Molecular Therapy. 2012;20(Suppl 1):S165.
30. Hsieh PF, Liu SF, Lee TC, Huang JS, Yin LT, Chang WT, Chuang LY, Guh JY, Hung MY, Yang YL. The Role of IL-7 in Renal Proximal Tubule Epithelial Cells Fibrosis. Molecular Immunology. 2012 Feb;50(1-2):74-82.
31. Yang YL, Ju HZ, Liu SF, Lee TC, Shih YW, Chuang LY, Guh JY, Yang YY, Liao TN, Hung TJ, Hung MY. BMP-2 Suppresses Renal Interstitial Fibrosis by Regulating Epithelial-Mesenchymal Transition. Journal of Cellular Biochemistry. 2011 Sep;112(9):2558-2565.
32. Lee TC, Wang CJ, Yang YL, Huang YH, Lin WC, Chang SY. Bone Morphogenetic Protein-2 Expression in Spinal Fusion Masses Enhanced by Extracorporeal Shock Wave Treatment: A Rabbit Experiment. Acta Neurochirurgica. 2010 Oct;152(10):1779-1784.
33. Wang CJ, Weng LH, Hsu SL, Sun YC, Yang YJ, Chan YS, Yang YL. pCMV-BMP-2-Transfected Cell-Mediated Gene Therapy in Anterior Cruciate Ligament Reconstruction in Rabbits. Arthroscopy. 2010 Jul;26(7):968-976.
34. Chiang TA, Yang YL, Yang YY, Hu MH, Wu PF, Liu SF, Huang RM, Liao TN, Hung CY, Hung TJ, Lee TC. Hyperosmolarity Enhanced Susceptibility to Renal Tubular Fibrosis by Modulating Catabolism of Type I Transforming Growth Factor-β Receptors. Journal of Cellular Biochemistry. 2010 Mar 1;109(4):663-671.
35. Chen SC, Guh JY, Hwang CC, Chiou SJ, Lin TD, Ko YM, Huang JS, Yang YL, Chuang LY. Advanced Glycation End-products Activate Extracellular Signal-regulated Kinase via the Oxidative Stress-EGF Receptor Pathway in Renal Fibroblasts. Archives of Biochemistry and Biophysics. 2010 Jan 1;109(1):38-48.
36. Yang YL, Liu YS, Chuang LY, Guh JY, Lee TC, Liao TN, Hung MY, Chiang TA. Bone Morphogenetic Protein-2 Antagonizes Renal Interstitial Fibrosis by Promoting Catabolism of Type I Transforming Growth Factor-β Receptors. Endocrinology. 2009 Feb;150(2):727-740.
37. Lee TC, Chang NK, Su FW, Yang YL, Su TM, Lin YJ, Lin WC, Huang HY. Systemic and Local Reactions of a Water-soluble Copolymer Bone on a Bony Defect of Rabbit Model. Surgical Neurology. 2009 Dec;72 Suppl 2:S75-S79.
38. Lee TC, Yang YL, Chang NK, Lin TS, Lin WC, Liu YS, Wang CJ. Biomechanical Testing of Spinal Fusion Segments Enhanced by Extracorporeal Shock Wave Treatment in Rabbits. Chang Gung Medical Journal. 2009 May-Jun;32(3):276-282.
39. Huang JS, Chuang LY, Guh JY, Yang YL, Hsu MS. Effect of Taurine on Advanced Glycation End Products-induced Hypertrophy in Renal Tubular Epithelial Cells. Toxicology and Applied Pharmacology. 2008 Dec 1;233(2):220-226.
40. Lee TC, Huang HY, Yang YL, Hung KS, Cheng CH, Lin WC, Wang CJ. Application of Extracorporeal Shock Wave Treatment to Enhance Spinal Fusion: A Rabbit Experiment. Surgical Neurology. 2008 Aug;70(2):129-134.
41. Yang YL, Chang SY, Teng HC, Liu YS, Lee TC, Chuang LY, Guh JY, Chang FR, Liao TN, Huang JS, Yeh JH, Chang WT, Hung MY, Wang CJ, Chiang TA, Hung CY, Hung TJ. Safflower Extract: A Novel Renal Fibrosis Antagonist that Functions by Suppressing Autocrine TGF-β. Journal of Cellular Biochemistry. 2008 Jan 11.
42. Wang HC, Yang YL, Lin WC, Chen WF, Yang TM, Lin YJ, Rau CS, Lee TC. Computer-assisted Pedicle Screw Placement for Thoracolumbar Spine Fracture with Separate Spinal Reference Clamp Placement and Registration. Surgical Neurology. 2008 Jan 17.
43. Chou WW, Guh JY, Tsai JF, Hwang CC, Chen HC, Huang JS, Yang YL, Hung WC, Chuang LY. Arecoline-induced Growth Arrest and p21(WAF1) Expression Are Dependent on p53 in Rat Hepatocytes. Toxicology. 2008 Jan 14;243(1-2):1-10.
44. Yang YL, Lin SH, Chuang LY, Guh JY, Liao TN, Lee TC, Chang WT, Chang FR, Hung MY, Chiang TA, Hung CY. CD36 Is a Novel and Potential Anti-fibrogenic Target in Albumin-induced Renal Proximal Tubule Fibrosis. Journal of Cellular Biochemistry. 2007 Jun 1;101(3):735-744.
45. Lee TC, Huang HY, Yang YL, Hung KS, Cheng CH, Chang NK, Chung YH, Hu MS, Wang CJ. Vulnerability of the Spinal Cord to Injury from Extracorporeal Shock Waves in Rabbits. Journal of Clinical Neuroscience. 2007 Sep;14(9):873-878.
46. Chen YH, Guh JY, Chuang TD, Chen HC, Chiou SJ, Huang JS, Yang YL, Chuang LY. High Glucose Decreases Endothelial Cell Proliferation via the Extracellular Signal-regulated Kinase/p15(INK4b) Pathway. Archives of Biochemistry and Biophysics. 2007 Jun 4.
47. Chen SC, Guh JY, Chen HC, Yang YL, Huang JS, Chuang LY. Advanced Glycation End-product-induced Mitogenesis Is Dependent on Janus Kinase 2-induced Heat Shock Protein 70 in Normal Rat Kidney Interstitial Fibroblast Cells. Translational Research. 2007 May;149(5):274-281.
48. Chuang TD, Guh JY, Chiou SJ, Chen HC, Huang JS, Yang YL, Chuang LY. Phosphoinositide 3-Kinase Is Required for High Glucose-induced Hypertrophy and p21WAF1 Expression in LLC-PK1 Cells. Kidney International. 2007 May;71(9):867-874.
49. Lee TC, Ho JT, Hung KS, Chen WF, Chung YH, Yang YL. Bone Morphogenetic Protein Gene Therapy Using a Fibrin Scaffold for a Rabbit Spinal-fusion Experiment. Neurosurgery. 2006 Feb;58(2):373-380.
50. Liu HC, Liao TN, Lee TC, Chuang LY, Guh JY, Liu SF, Hu MS, Yang YL, Lin SH, Hung MY, Huang JS, Hung TJ, Chen CD, Chiang TA, Chan JY, Chen SY, Yang YL. Albumin Induces Cellular Fibrosis by Upregulating Transforming Growth Factor-β Ligand and Its Receptors in Renal Distal Tubule Cells. Journal of Cellular Biochemistry. 2006 Apr 1;97(5):956-968.
51. Yeh JH, Cheng HH, Huang CJ, Chung HM, Chiu HF, Yang YL, Yeh MY, Chen WC, Kao CH, Chou CT, Jan CR. Effect of Anandamide on Cytosolic Ca(2+) Levels and Proliferation in Canine Renal Tubular Cells. Basic & Clinical Pharmacology & Toxicology. 2006 Apr;98(4):416-422.
52. Huang JS, Chuang LY, Guh JY, Chen CJ, Yang YL, Chiang TA, Hung MY, Liao TN. Effect of Nitric Oxide-cGMP-dependent Protein Kinase Activation on Advanced Glycation End-product-induced Proliferation in Renal Fibroblasts. Journal of the American Society of Nephrology. 2005 Aug;16(8):2318-2329.
53. Lee CI, Guh JY, Chen HC, Hung WC, Yang YL, Chuang LY. Advanced Glycation End-product-induced Mitogenesis and Collagen Production Are Dependent on Angiotensin II and Connective Tissue Growth Factor in NRK-49F Cells. Journal of Cellular Biochemistry. 2005 May 15;95(2):281-292.
54. Yang YL, Chuang LY, Guh JY, Liu SF, Hung MY, Liao TN, Huang YL. Thrombospondin-1 Mediates Distal Tubule Hypertrophy Induced by Glycated Albumin. Biochemical Journal. 2004 Apr 1;379(Pt 1):89-97.
55. Lee CI, Guh JY, Chen HC, Lin KH, Yang YL, Hung WC, Lai YH, Chuang LY. Leptin and Connective Tissue Growth Factor in Advanced Glycation End-product-induced Effects in NRK-49F Cells. Journal of Cellular Biochemistry. 2004 Nov 15;93(5):940-950.
56. Chuang LY, Guh JY, Liu SF, Hung MY, Liao TN, Chiang TA, Huang JS, Huang YL, Lin CF, Yang YL. Regulation of Type II Transforming Growth Factor-β Receptors by Protein Kinase C Iota. Biochemical Journal. 2003 Oct 15;375(Pt 2):385-393.
57. Yang YL, Guh JY, Yang ML, Lai YH, Tsai JH, Hung WC, Chang CC, Chuang LY. Interaction between High Glucose and TGF-β in Cell Cycle Protein Regulations in MDCK Cells. Journal of the American Society of Nephrology. 1998 Feb;9(2):182-193.
58. Yang ML, Guh JY, Yang YL, Chang CC, Chuang LY. Captopril Reverses High Glucose-induced Effects on LLC-PK1 Cells Partly by Enhancing Facilitative Glucose Transporter Messenger RNA Expressions. Biochemistry and Molecular Biology International. 1997;41(3):511-519.
59. Yang ML, Guh JY, Lai YH, Yang YL, Chang CC, Tsai JH, Chuang LY. Effects of High Glucose Culture on EGF Effects and EGF Receptors in the LLC-PK1 Cells. American Journal of Nephrology. 1997;17(2):193-198.
60. Guh JY, Yang ML, Yang YL, Chang CC, Chuang LY. Captopril Reverses High-glucose-induced Growth Effects on LLC-PK1 Cells Partly by Decreasing Transforming Growth Factor-β Receptor Protein Expressions. Journal of the American Society of Nephrology. 1996 Aug;7(8):1207-1215.

 

List of Recent Research Projects Led or Participated in

by the Principal Investigator

　

專業證照

以臨床生化滿分成績取得醫事檢驗師國家執照。發照單位：考選部。

特定化學物質作業主管證照。發照單位：中華民國工業安全衛生協會。

醫學實驗室認證規範ISO15189訓練合格證書。發照單位：財團法人全國認證基金會。

TQC-OA 辦公室軟體應用類專案管理證照 (2010/11/25) 級別: 專業級。

TQC-DK 專業知識領域, 電子商務概論 專案管理證照 (2010/11/25) 級別: 專業級。 

國際期刊審查委員(Reviewer in SCI journals)

BMC Complementary and Alternative Medicine (2013, Mar)

Pharmacological Reports (2012, Dec)

Apoptosis (2012, Sep)

Clinical Biochemistry (2012, Apr)

Journal of Research in Environmental Science and Toxicology (2012, Jan)

African Journal of Microbiology Research (2011, Nov)

Journal of Medical Plants Research (2011, Oct)

International Journal of Fisheries and Aquaculture (2011, Aug)

Journal of Diabetes and Endocrinology (2011, June)

International Journal of Nutrition and Metabolism (2011, Jan)

Journal of Metabolomics and Systems Biology (2010, Nov)

International Journal for Biotechnology and Molecular Biology Research (2010, Oct)

Journal of Medicine and Medical Sciences (2010, Oct)

African Journal of Pharmacy and Pharmacology (2010, Sep)

Journal of Pediatric Biochemistry (member in the Reviewer Board, (2010 )

African Journal of Biotechnology (2010, May)

Acta Pharmacologica Sinica (2009)

Journal of Dermatological Science (2008)

Pharmacological Research (2007)

其他國際學術資歷

Book Authors:  Yu-Lin Yang , Wen- Teng Chang and Yuan-Wei Shih, "Gene Therapy, Chapter title: Gene Therapy Using RNAi".

InTech (Open Access Publisher) [ISBN: 978-953-307-240-1] (2011)

Book Authors: entitled "Renal Diseases" InTech - Open Access Publisher [ISBN: 978-953-308-58-7] (2011)

Editorial Board Member in "Journal of Biotechnology & Biomaterials" (OMICS Publishing Group, Los Angeles CA-91362-7354, USA 2011)

Contributing Editor in American Journal of Biochemistry and Biotechnology

Consultancy: EPS Global Medical Development Inc. (2011)

Editor in the Journal of Steroids & Hormonal Science (2011)

 

審查委員

經濟部鼓勵中小企業開發新技術推動計畫(SBIR) 計畫審查委員

台南縣鼓勵中小企業開發新技術推動計畫(SBIR) 計畫審查委員

台南市鼓勵中小企業開發新技術推動計畫(SBIR) 計畫審查委員

教育部學術審查委員會升等審查委員

國科會專題計畫審查委員

擔任教學行政工作之具體績效

107年擔任副校長/教務長爭取教育部高教深耕計畫近四千萬

103年擔任教務長爭取教育部教學卓越計畫近三千五百萬

100年度本校獲大專院校友善校園學務與輔導績優學校南區43所大專院校中第一名(2011)

100年度本校獲全國友善校園學務與輔導績優學校(2011)

99年本校獲校務評鑑學務評鑑獲一等(2010)

98年度本人兼代軍訓室主任任內，本校獲全民國防教育評鑑一等績優學校(2009)

98-100年度導師輔導回饋成績績優(2009-2011)

97年本校獲得全國品德教育績優學校(2008)

科技與學術顧問

高雄市生物科技園區推動委員會專案顧問

台南縣政府創新育成中心生物科技技術顧問

屏東農科產業園區籌設委員之一

技術轉移 

技術轉移案號	技轉名稱	技轉對象	技術權利
編號: C1020603008	山藥有效萃取物diosgenin對腎纖維化控制技術之平台	連宏實業有限公司	102年6月1日至103年5月31日
編號: C1010712011 (技10101002)	以幹細胞平台開發纖維化控制技術之應用	啟瀚科技有限公司	101年7月15日至101年12月15日
編號: C1010303001 (技10101001)	山藥萃取物對腎纖維化控制技術之應用	連宏實業有限公司	101年4月1日至101年10月1日
編號: 10001003	以免疫生長因子開發腎纖維化控制技	啟瀚科技有限公司	100年6月1日至100年12月1日
編號:10001002	開發酵素對抗腎纖維治療之平台	貫閎開發生技股份有限公司	100年1月1日至100年10月31日
編號:10001001	以北蟲草萃取液對抗腎纖維治療之開發	欣潤生物科技股份有限公司	100年1月1日至100年10月31日

 

 

　

　

　

　

　

　

 

個人專案研究計畫與研究方向

Professor Yang Yu-Lin (Ph.D.-medicine), now is Dean of Academic Affairs from Chung Hwa University of Medical Technology, Taiwan.

He got his B Sc in the department of biomedical laboratory Science and Medicine Doctor's degree (Ph.D.) at Graduate Institute of Medicine in Kaohsiung Medical University in 2000 with outstanding phD thesis award.

As a specialist in Biomedical Science, he is the pioneer director for the department of biomedical science and institute of biomedical science in Chung Hwa University of Medical Technology.

He is the chairman for Biological Safety Council and Biomedical Science research group in the University.

He is also the Editorial Board Member in Journal of Biotechnology & Biomaterials (OMICS Publishing Group, Los Angeles) and contributing editor in American Journal of Biochemistry and Biotechnology.

He is invited as reviewers for many journals (including International academic Journal, Journal of Dermatological Science, Acta Pharmacologica Sinica, Journal of Pediatric Biochemistry, International Journal for Biotechnology and Molecular Biology Research).

He is also invited as an advisor for Small Business Innovation Research (SBIR) Program Review Committee for Tainan city government and advisor for Kaohsiung Biotechnology Science Park in Taiwan.

Prof. Yang has recently been honored and elected as the outstanding researcher Award in 2010 in Taiwan (Top 6% in Taiwan), and being elected as a distinguished young scholarship 3-year grand (2010-2012) by National Science Council.

Under the support of Australia Academy of Science and National Science Council in Taiwan, he was invited as a visiting professor for University of Queensland (School of Biomedical Science, SBMS, Australia) in 2013.

現職及專長相關之經歷

服務機關	服務部門/系所	職稱	起訖年月
中華醫事科技大學	醫事學院院長	院長	2021.8-至今
經歷 ：
中華醫事科技大學	主任秘書室	主任秘書兼副校長	2020.8-2021.7
中華醫事科技大學	教務處	教務長兼副校長	2014.8-2020.7
中華醫事科技大學	學生事務處	教授兼任學生事務長	2008.8-2013.7
中華醫事科技大學	生物科技系暨生物醫學 研究所	副教授兼任系主任 (所長)	2004.12-2008.7
中華醫事學院	生物科技系	副教授	2004.12 -
中華醫事學院	生物科技系	副教授	2004.12 -
高雄市政府	高雄生物科技園區推動 委員會	顧問	2002.09-2004.09
台南縣政府	創新育成中心	顧問	2002.09-2004.08
中華醫事學院	生物科技系	系主任	2002.07-2005.06
中華醫事學院	醫技系	生物科技系籌備主任	2002.02-2002.07
中華醫事學院	醫技系	助理教授	2000.08-2002.0

　

專利技術

專利案號	專利名稱	專利種類	申請(送件)時間
編號106131439	NRF-1蛋白質用以製備治療膀胱癌之藥物的用途	發明專利	2018-12-25核准
編號I527589	Nrf-1蛋白質之用途	發明專利	2016-04-01核准
編號PK14006	PGC-1A抑制劑之用途	發明專利	申請中
編號I494118	使用山藥植物(Dioscorea spp. plant)之經水萃取的產物來治療糖尿病腎病變	發明專利	2015-05-01核准
編號I444193	使用牛膝之經乙醇萃取的產物來治療肝纖維化	發明專利	2014-07-11核准
編號I442929	木樨植物治療肺纖維化	發明專利	2014-07-01核准
編號I421082	蛻皮激素用以製備治療腎纖維化藥物之用途及醫藥組合物用以製備治療腎纖維化之藥物的用途	發明專利	2014-01-01核准
編號I415621	介白素７用以製備治療腎纖維化藥物之用途及醫藥組合物用以製備治療腎纖維化之藥物的用	發明專利	2013-11-21核准
校內案號 C1020515008	輕便型快速微量吸管尖補充器	新型專利	2013-5-21
校內案號C1020515007	可變動式微量吸管尖盒	新型專利	2013-5-21
校內案號C1020528003	以DIOSGENIN調節腎細胞(近端腎小管)細胞纖維化	發明專利	2013-5-29
編號I386218	使用王不留行之經乙醇萃取的產物來治療糖尿病腎病變引發之腎纖維化	發明專利	2013-02-21核准
公開號201347766	使用木樨植物水萃產物來處理肺臟細胞纖維化	發明專利	2010-11-11 2012-5-28送件 2014-4-15通過
專利局申請碼PK12196 (核准案號I415612)	Interleukin 7抑制腎纖維化之應用	發明專利	2011-07-12 2013-11-21通過
專利局申請碼PK12195 核准案號I421082	蛻皮激素作為藥物治療組織纖維化	發明專利	2011-07-12 2014-1-1通過
校內案號C0991111010 專利局申請案號101111701	杜牛膝萃取物對於抗肝纖維化治療之應用	發明專利	2010-11-11 2012-4-2送件
專利局申請碼 100209225 (核准案號M418288)	可自行控制長度的微量分注器	新型專利	2010/12/30 2011/5/23送件 2011-12-11核准
專利局申請碼 100209226 (核准案號M413091)	安全性酒精燈	新型專利	2010/12/30, 2011/5/23送件 2011-10-01核准
專利局申請碼 98120616 (核准案號201100089)	使用山藥植物之經水萃取的產物來治療糖尿病腎病變	發明專利	2009/6/19送件

 

歷年主持之專案研究計畫

狀態	計畫主題（編號）	計畫期限	核定計畫經費
執行中	探討NRF1合併臨床用藥對於肺癌細胞粒線體自噬與治療成效 (VHYK115-01)	2026/01/01～2026/12/31	NT$727,500
執行中	探討NRF對端粒調控與幹細胞分裂分化能力與再生醫學應用114-2637-8-273 -001 -	2025/08/01 ~ 2026/07/31	NT$2,200,000
執行中	粒線體動態在EPS8調控的前列腺癌抗藥性之角色研究(EDAHS114029)	2025/07/01～2025/06/30	NT$299,213
執行中	NRF1調控粒線體功能對於皮膚癌細胞生長的影響 機制研究 (CCFHR11405)	2025/01/01～2025/12/31	NT$300,000
執行中	以SCID老鼠轉殖人類肺癌腫瘤細胞A549的肺癌實驗模型，探討調控粒線體生合成對於腫瘤發展的影響與腫瘤治療效果 (VHYK114-08)	2025/01/01～2025/12/31	NT$535,000
結案	機能性活性成份介入對犬隻端粒調節與臨床生理綜合分析 (產業合作)	2025/01/01～2025/12/31	NT$360,000
結案	內質網壓力在毛蕊花苷調控賀爾蒙抗性前列腺癌細胞衰老中的作用 (EDAHP114023)	2025/01/01～2025/12/31	NT$250,000
結案	分泌載體膜蛋白三與表皮生長因子受體激酶底物八/表皮生長因子受體在去勢抗性前列腺癌細胞增殖中相互作用機轉 (EDAHP113006)	2024/01/01～2024/12/31	NT$300,000
結案	探討肺癌細胞侵襲性與上皮間質轉換機轉和細胞能量調節對於腫瘤發展的影響 (VHYK113-01)	2024/01/01～2024/12/31	NT$450,000
結案	機能食品補充物對端粒長度調節探討 (產業合作)	2023/09/15～2024/09/14	NT$130,000
結案	特定機能保養品對粒線體能量調節探討 (產業合作)	2023/11/01～2024/10/31	NT$129,900
結案	石斑魚體表黏液胜肽對端粒酶長度的影響 (產業合作)	2023/02/01～2024/01/31	NT$100,000
結案	探討Neuregulin-1透過調控細胞衰老在賀爾蒙抵抗性前列腺癌細胞抗藥性發展中的作用 (EDAHP112027)	2023/01/01～2023/12/31	NT$168,000
結案	探討丹參有效物質於攝護腺癌調控與治療之機轉 (EDCHP112013)	2023/01/01～2023/12/31	NT$168,000
結案	細胞能量醫學專題分享與訊息能量分析 (產業合作)	2022/09/15～2023/09/14	NT$100,000
結案	研究毛蕊花苷對賀爾蒙抵抗性前列腺癌細胞衰老現象及調節機制 (EDAHP111053)	2022/01/01～2022/12/31	NT$168,000
結案	探討粒線體生合成轉錄因子NRF-1於膀胱癌治療機制中扮演的角色 (EDCHP109010)	2020/01/01～2020/12/31	NT$350,000
結案	探討Rutin於攝護腺癌調控與治療之機轉 (EDAHP109047)	2020/01/01～2020/12/31	NT$200,000
結案	師生與社區居民電子健康紀錄資料的收集分析	2020/07/10~2021/07/09
結案	探討第一型和呼吸因子NRF-1與粒線體調節對肺癌治療的角色	2020/02/01~2022/01/31	1,200,000元
結案	探討微粒/神經調節蛋白對腎纖維化調節的角色	2019/08/01~2020/07/31	850,000元
結案	桂花純物質對於皮膚細胞功效分析與相關應用	2017/09/01~2019/08/31
結案	探討桂花有效物質調節前列腺癌之作用機制	2018/01/01~2018/12/31	200,000元
結案	探討去氫固醇於腎纖維化之治療應用     VHYK-015	2018/01/01~2018/12/31	500,000元
結案	在腎絲球足細胞下探討纖維化誘導因子（TGF-β1）刺激下ROS、 ER stress與粒線體生合成的交互作用 ( 106-2314-B-273 -001 -)	2017/08/01~2018/07/31	科技部 850,000元
結案	探討粒線體生合成轉錄因子NRF-1於腎纖維化調節或治療上的角色(105-2314-B-273-002-)	2016/08/01~2017/07/31	科技部計畫： [1,050,000元]
結案	蛋白尿引發integrin-β3藉以增加腎絲球足細胞的移行	201/701/01~2017/12/31	300,000元
結案	探討粒線體生合成轉錄因子NRF-1於腎纖維化調節或治療上的角色 高雄榮總台南分院院長王志龍 （編號T009）	2017/01/01~2017/12/31	748,572元
結案	產學計畫:  探討粒線體生合成轉錄因子PGC-1α於腎纖維化調節或治療上的角色（編號T001） 高雄榮總台南分院 外科主任 陳進旺	2017/01/01~2017/12/31	424,222元
結案	紅景天有效活性物質紅景天苷於膀胱纖維化保護功效評估Evaluation of the protective role of active Rhodiola rosea against bladder fibrosis.	2016/01/01~2016/12/31	200,000元
結案	探討粒線體生合成因子NRF1之控制對於腎臟纖維化控制的角色	2015/12/01~2017/11/30
結案	教育部產學計畫: 開發運用三維介電泳微流體晶片技術於糖尿病視網膜病變的快速篩檢平台	2015/06/01~2016/05/31
結案	屏東區域產學補助產學研發亮點成果 探討IL-7於腎近端小管細胞纖維化的角色	2014/09/01~2014/12/31
結案	探討Diosgenin與能量感應訊息路徑AMPK/SIRT1/PGC-1於腎臟纖維化之調節角色與機轉	2014/08/01 ~ 2015/07/31	科技部計畫 [980,000元]
結案	產學計畫: 探討能量調節蛋白PGC1alpha之控制對於腎臟纖維化控制的角色	2014/07/01~2016/10/31
結案	教育部產學計畫:  探討去氫固醇於肝纖維化之治療應用	2013/05/15~2014/12/31
結案	大學實施頂尖人才彈性薪資申請計畫	2013/08~2016/07/31	教育部計畫
結案	山藥活性物質Diosgenin之護肝功效評估 (103B-17-007, 聯群生技股份有限公司) (103年教育部產業園區產學合作計畫)	2014/01/22 ~2014/12/31 (教育部)	1,425,000元 (教育部675,000+學校150,000+ 企業600,000)
結案	大學實施頂尖研發人才彈性薪資申請計畫 (全國唯一連獲6年彈性薪資計畫)	2010/8 ~ 2016/07/31  (教育部)	3,600,000元 (含校配合)
結案	科技部補助大專校院獎勵特殊優秀人才計畫 (NSC 102－3114－C－273－001－ES)	2013/08/01 ~ 2014/07/31 (科技部)	732,442 (全校) 120,000 (個人)
結案	教育部補助102學年度技職校院建立策略聯盟計畫	2013/08 ~2014/07   (教育部)	364,000 + 72,800(配合款)
結案	探討胸腺基質淋巴生成素於糖尿病腎臟病變的角色與抗纖維化之臨床應用（NSC 99-2628-B-273 -001 -MY3）行政院國科會傑出學者養成計畫(個別型)	2010/08/01 ~ 2013/07/31 (國科會)	4,110,000元 (全國私立科大補助金額最高)
結案	以免疫治療方式對抗腎纖維化之功效 (連宏生技股份有限公司)	2011/05/01~2011/07/31 (教育部產學合作計畫)	60,000元
結案	活血中草藥發酵產物抗腎纖維化功效之開發 (貫閎開發生技股份有限公司)	2011/01/01~2011/05/31 (教育部產學合作計畫)	60,000元
結案	99年度南區區域教學資源中心計畫 (分項計畫三: 主持人) 提升學生學習成效促進室性發展	2010/02/01~2011/06/30 (教育部區域教學卓越計畫)	約1,200,000元
結案	100年度南區區域教學資源中心計畫 (分項計畫三: 主持人)找自己:全方位發展與學習輔導關懷計畫	2011/07/01~2012/06/30 (教育部區域教學卓越計畫)	2,449,040元
結案	遞補學生事務與輔導人力計畫 (教育部)	2010/01/01~2010/12/31	4,771,750元
結案	比較未分化與骨分化間質幹細胞對脊椎融合的效果。以膠原蛋白為載體的兔子實驗	(國科會共同主持人)
結案	遞補學生事務與輔導人力計畫 (教育部)	2009/01/01~2009/12/31	4,992,910元
結案	利用中草藥晶片技術針對特定天然物進行抗腎纖維化分析與TGF-beta/受器/受器後Smad相關路徑機轉探討（NSC 96-2314-B-273-002-MY3 ）(國科會)	2007/08/01~2010/07/31	2,680,000 元
結案	以活血中草藥杜牛膝分析抗纖維化有效成分 （99B-17-036 ）(教育部園區產學合作計劃)	2010/01/25~2010/12/31	940,500 元 (MOE35,IND40)
結案	以台灣血藤進行抗腎纖維化有效成分之專利開發 (98B-17-025) (國科會/教育部)	2009/01/01~2009/12/31	894,500 元
結案	學界協助中小企業科技關懷計畫診斷計畫書 (教育部/金屬中心)	2009/01/01~2009/06/31	30,000 元
結案	建構中草藥活性活性成分篩選平台以提昇產業既有技術之經濟價值 (B-17-037)	2008/06/01~2009/01/31	897,000元
結案	人類乳突病毒E2基因之研究	華產96 2008/01/01~2008/06/30	110,500  (配合25,500)
結案	以生物晶片配合定量聚合酵素反應開發快速篩檢纖維化等疾病基因表現平台	華產96 2007/12/01~2008/05/31	133,900 (配合30,900 )
結案	探討第二型骨頭成型蛋白在糖尿病腎纖維化上治療的角色	NSC 95-2314-B273-003	814,000元
結案	中草藥指標、有效成分與標準品之研究與開發 (衛生署)	CCMP95-TP-007 2006/5/26~2006/12/31	1342,000元 (配合400,000)
結案	運用第二型血管加壓素抑制劑與第二型乙型轉型生長因子受器干擾性RNA之「雙重抑制策略」在糖尿病腎臟纖維化治療上之研究	NSC 94-2314-B273-001	816,000 元
結案	探討TGF-beta R1/RII與atypical PKC對糖尿病腎病變之纖維化的角色	NSC 93-2314-B273-001	1,020,000 元
結案	探討CD36及受器後訊息傳導路徑在治療糖尿病腎病變之纖維化的角色	NSC 92-2314-B273-001	650,000元
結案	以轉錄因子誘餌探討逆轉高度糖化終產物所誘導腎臟細胞thrombospondin-1過量表現與細胞病變的可行性	NSC 91-2314-B-273 -005	1,020,000元
結案	轉錄因子AP-1與NF-kappaB在高糖誘導腎小管細胞株之乙型轉型生長因子第二型受器表現所扮演的角色	NSC 90-2314-B-273-003	870,000元

 

International Invited Lectures

Year	Lecture / Event Title	Inviting Institution	Location	Category	Role
2026	HAWI–NUS International Symposium: From Synapse to Telomere: Biological Regulation of Brain Aging	National University of Singapore (NUS) × Chung Hwa University of Medical Technology (CHUMT)	Tainan, Taiwan	International Symposium	Invited Speaker (Key Session)
2026	Telomere Regulation and Cellular Aging in Dementia	HAWI–NUS International Symposium	Tainan, Taiwan	International Academic	Invited Speaker
2026	Telomere and Cognitive Regeneration (TELOMIND-NRF Project)	Universitas Pelita Harapan (UPH) / MRIN	Jakarta, Indonesia	International Academic	Invited Speaker
2025	NRF and Brain Aging Mechanisms	National University of Singapore (NUS)	Singapore	Top-tier International University	Invited Speaker
2023	Immunology Special Lecture	Taiwanese Academic Community in Australia	Australia	International Academic	Invited Speaker
2023	NRF Regenerative Factor Lecture	National Taiwan University	Taipei, Taiwan	Academic	Invited Speaker
2013	International Drug Discovery Science and Technology EXPO (IDDST 2013)	International Drug Discovery Conference	Haikou, China	International Conference	Invited Speaker
2013	Biomedical Science Lecture	Academic Institutions in Brisbane	Brisbane, Australia	International Academic	Invited Speaker
2013	Biomedical Research Seminar	University of Queensland (SBMS)	Queensland, Australia	International Academic	Invited Speaker
2013	32nd Annual Meeting of the Korean Endocrine Society	Korean Endocrine Society	Seoul, South Korea	International Conference	Invited Speaker
2013	Medical & Biotechnology Academic Exchange	Xinxiang Vocational Institute & Zhengzhou Shuqing Medical College	Henan, China	International Academic Exchange	Invited Speaker